← All Sponsors
SPONSOR

Pierre Fabre Pharma GmbH

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Melanoma Stage IVMelanoma Stage III
NCT04045691
Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Melanoma Stage IV
Austria, Germany, Switzerland View Trial →